Leerink Adjusts Price Target on Cardinal Health to $122 From $120, Maintains Outperform Rating
Deutsche Bank Adjusts Cardinal Health Price Target to $115 From $110
JPMorgan Adjusts Cardinal Health Price Target to $111 From $119
Cardinal Health Analyst Ratings
Argus Adjusts Price Target on Cardinal Health to $115 From $120
Cardinal Health: A Steady Hold Amid Moderate Growth and Diversification Efforts
Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116
Cardinal Health: Hold Rating Affirmed Amidst Mixed Financial Outlook and Strategic Focus
Jefferies Cuts Cardinal Health's Price Target to $105 From $110
Wells Fargo Raises Cardinal Health's Price Target to $95 From $94
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Kura Oncology (KURA) and Amgen (AMGN)
Cardinal Health Analyst Ratings
Leerink Partners Adjusts Cardinal Health Price Target to $120 From $118
Cardinal Health Analyst Ratings
Analyst Issues Sell Rating for Cardinal Health Amid Major Contract Loss and Revenue Decline Concerns
Evercore ISI Adjusts Cardinal Health's Price Target to $110 From $118, Keeps In Line Rating
Cardinal Health Faces Earnings Uncertainty Post OptumRx Contract Loss: Analyst Holds Rating
Maintaining a Buy Rating: Cardinal Health's Strong Fundamentals and Growth Prospects Despite OptumRx Contract Loss
Analysts' Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Pfizer (PFE) and Cardinal Health (CAH)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Cardinal Health (CAH) and Madrigal Pharmaceuticals (MDGL)